Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

Michael S Anderson,1 Anish Nadkarni,1 Leah A Cardwell,1 Hossein Alinia,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, 2Department of Pathology, 3Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA Background: Br...

Full description

Bibliographic Details
Main Authors: Anderson MS, Nadkarni A, Cardwell LA, Alinia H, Feldman SR
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Patient Preference and Adherence
Subjects:
brimonidine
rosacea
efficacy
patient satisfaction
safety
adverse reactions
side effects
acceptability
Online Access:https://www.dovepress.com/spotlight-on-brimonidine-topical-gel-033-for-facial-erythema-of-rosace-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/spotlight-on-brimonidine-topical-gel-033-for-facial-erythema-of-rosace-peer-reviewed-article-PPA

Similar Items